Universe · entity
Sanofi
Institutional manager (13F) · CIK 1121404
13F holdings · as of 2026-03-31 · top 9 · reported portfolio $336M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | MeiraGTx Holdings plc | $106M | 12,197,737 |
| 2 | Inhibrx Biosciences, Inc. | $78M | 1,157,926 |
| 3 | Novavax | $56M | 6,880,481 |
| 4 | AnaptysBio | $30M | 821,917 |
| 5 | Agomab Therapeutics NV | $29M | 2,783,096 |
| 6 | MapLight Therapeutics Inc. | $19M | 912,041 |
| 7 | Immuneering Corp | $14M | 2,708,559 |
| 8 | Eledon | $3M | 814,980 |
| 9 | Q32 Bio Inc. | $2M | 244,083 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.